Effectiveness and safety of high-dose dual therapy PPI-amoxicillin dual therapy for first-line Helicobacter pylori in Chile: Experience from the retrospective study

Simple item page
dc.coverageDOI: 10.1016/j.gastrohep.2022.12.001
dc.creatorQuera, Rodrigo
dc.creatorCórdova, Andrea
dc.creatorNúñez, Paulina
dc.creatorvon Muhlenbrock, Christian
dc.date2023
dc.date.accessioned2025-11-18T19:42:24Z
dc.date.available2025-11-18T19:42:24Z
dc.identifierhttps://investigadores.uandes.cl/en/publications/2dbd6b35-b785-4df5-9a56-4b695f6c873d
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/52314
dc.languageeng
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourcevol.46 (2023) nr.10 p.806-808
dc.titleEffectiveness and safety of high-dose dual therapy PPI-amoxicillin dual therapy for first-line Helicobacter pylori in Chile: Experience from the retrospective studyeng
dc.titleEfectividad y seguridad de la terapia dual IBP-amoxicilina en dosis altas como terapia de primera línea en la erradicación de Helicobacter pylori en Chile: experiencia desde un estudio retrospectivospa
dc.titleEffectiveness and safety of high-dose dual therapy PPI-amoxicillin dual therapy for first-line Helicobacter pylori in Chile: Experience from the retrospective study: Experience from the retrospective studyeng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE